ClinicalTrials.Veeva

Menu

A New Parameter Derived From DSA to Evaluate Cerebral Perfusion

X

Xi'an No.3 Hospital

Status

Enrolling

Conditions

Cerebral Ischemia

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

This observational study focus on a new parameter of cerebral perfusion derived form digital substraction angiography.

Full description

Ischemic cerebrovascular disease is an important cause of death and disability in the world. Digital Subtraction Angiography (DSA) is the golden index for evaluating cerebral blood vessels. We introduced a new parameter derived from DSA to evaluate the perfusion to predict the outcomes in acute stroke with large vessel occlusion.

To study the possible relationship between the new parameter of cerebral perfusion derived from DSA and outcomes in cerebral ischemia(modified Rankin Scale), we intend to retrospectively analyze the images derived from patients who undergone the DSA and follow-up outcomes(modified Rankin Scale).

Enrollment

30,000 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Cerebral ischemia
  2. patients undergone DSA

Exclusion criteria

1.cerebral hemorrhage

Trial design

30,000 participants in 3 patient groups

good perfusion in DSA
Description:
We introduced a new parameter derived from DSA to evaluate the perfusion in cerebral ischemia.(good perfusion)
middle perfusion in DSA
Description:
We introduced a new parameter derived from DSA to evaluate the perfusion in cerebral ischemia.(middle perfusion)
poor perfusion in DSA
Description:
We introduced a new parameter derived from DSA to evaluate the perfusion in cerebral ischemia.(poor perfusion)

Trial contacts and locations

1

Loading...

Central trial contact

Tian Ye, doctor

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems